Explore a diverse range of topics, from water-related search and rescue to firearms examination, at this exclusive symposium. Dive deep into real-world case studies covering deaths related to alcohol consumption, electrocution, huffing, and more. Participants will also have the opportunity to attend breakout sessions on search and rescue, firearms, and K9 units for hands-on learning.
Mayo Clinic Laboratories is grateful for the opportunity to serve you and other healthcare professionals around the globe in providing critical answers and actionable insights.
The 24th International Surgical Pathology Symposium is an exciting opportunity for practicing surgical pathologists to expand their knowledge and skills. Presented by Mayo Clinic Laboratories, this four-day conference will address common and uncommon diagnostic dilemmas encountered within surgical pathology practice.
Mayo Clinic Laboratories is excited to participate in the 65th ASH Annual Meeting & Exposition, which will take place in San Diego on Dec. 9–12, 2023.
Mayo Clinic Laboratories, a leading global reference laboratory, and Progentec Diagnostics, a digital health and biomarker technology-based company focused on autoimmune conditions, today announced a strategic collaboration to bring Progentec’s suite of proprietary biomarker blood tests for the proactive management of autoimmune diseases to market. The collaboration aims to increase accessibility for providers and patients across the U.S. and select global markets.
Join Mayo Clinic Laboratories at the National Society of Genetic Counselors (NSGC) Annual Conference. Our interactive booth will be staffed by genetic counselors who can discuss and answer questions about our genetic testing options.
Mayo Clinic Laboratories is committed to security and to protecting your information. As part of this commitment, we will implement an optional two-step login process for Mayo Clinic Laboratories applications called Multi-Factor Authentication (MFA). This process is like the two-step login process used by many other apps and provides an extra layer of security.
This fall, healthcare professionals and laboratory outreach enthusiasts will travel to Chicago to attend Mayo Clinic's annual conference, "Leveraging the Laboratory." Outreach manager Jane Hermansen along with outreach solution strategists, Ellen Dijkman Dulkes and Brianne Newton, are excited to extend a warm welcome to fellow colleagues and peers. This year's conference will be held in the Windy City for the first time, promising an exceptional experience for all participants.
Hurricane Hilary will be impacting the West Coast this weekend and into early next week. We are monitoring and tracking the situation with our logistics partners to minimize challenges. Clients will be contacted directly by the couriers if a route is modified or canceled due to the storm. Additionally, we are identifying and activating alternate solutions to help deliver client specimens to Mayo Clinic Laboratories.
A team of researchers has confirmed that neutralizing monoclonal antibody (nMAb) therapies are associated with reduced risk of adverse outcomes of COVID-19 in high-risk populations. The cohort study, published in JAMA, included more than 167,000 nonhospitalized patients from health care systems based in California, Texas, and Utah, and at Mayo Clinic in Rochester, Minnesota.
Visit Mayo Clinic Laboratories at booth #2047 to learn about our comprehensive therapeutics test offerings. Developed by board-certified experts in clinical chemistry, molecular, and toxicology testing, our testing is designed to detect and monitor therapeutic and illicit drugs across several relevant specimen types.
Join us for the APA Annual Meeting 2023, the premier event for psychiatrists and mental health professionals. This year's meeting will be held May 20–24 in San Francisco and will feature an exciting program of educational sessions, expert speakers, and networking opportunities.
A medical mystery surrounding a clotting disease spurred a collaboration between Mayo Clinic and University of Michigan Health to develop a new test methodology and the discovery of a previously unknown blood clotting condition.